Despite being highly preventable, cervical cancer is the fourth most common cancer and
cause of cancer death in women globally. In low‐income countries, cervical cancer is often …

Barriers to successful implementation of the human papillomavirus vaccination exist.
However, there is limited evidence on implementation strategies in sub-Saharan Africa …

Introduction The human papillomavirus (HPV) vaccination is an important preventive
measure for HPV-related conditions such as cervical cancer. In 2019, Zambia introduced a …

Parental consent for adolescent human papillomavirus (HPV) vaccine uptake is important;
however, refusal is prevalent. Therefore, this study aimed to understand factors associated …

Introduction In settings with high HIV prevalence, cervical cancer incidence rates are up to
six‐fold higher than the global average of 13.1 cases per 100,000 women‐years. To inform …

Purpose Cervical cancer disproportionately impacts women in low-and middle-income
countries (LMICs). The World Health Organization's (WHO) 90/70/90 strategy aims to …

Background Despite the increased risk of cervical cancer (CC) among women living with
HIV (WLHIV), CC screening and treatment (CCST) rates remain low in Africa. The integration …

Countries with high HIV prevalence, predominantly in sub-Sahahran Africa, have the highest
cervical cancer rates globally. HIV care cascades successfully facilitated the scale-up of …

Cervical cancer can be prevented, primarily by the administration of the human
papillomavirus (HPV) vaccine. Healthcare workers (HCWs) and teachers play important …

INTRODUCTION To eliminate cervical cancer (CC), access to and quality of prevention and
care services must be monitored, particularly for women living with HIV (WLHIV). We …